P

Inventor

MACIELAG MARK J

US56 patents
⚠️ This page may combine multiple inventors who share the name “MACIELAG MARK J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN PHARMACEUTICA NV

26 patents
US8759333B2Jun 24, 2014

Di-azetidinyl diamide as monoacylglycerol lipase inhibitors

JANSSEN PHARMACEUTICA NV45 citations94
US8685990B2Apr 1, 2014

Pyrimidine compounds as delta opioid receptor modulators

JANSSEN PHARMACEUTICA NV19 citations92
US8748417B2Jun 10, 2014

Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors

JANSSEN PHARMACEUTICA NV9 citations84
US7179805B2Feb 20, 2007

7-amino alkylidenyl-heterocyclic quinolones and naphthyridones

JANSSEN PHARMACEUTICA NV15 citations80
US11230526B1Jan 25, 2022

Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptors

JANSSEN PHARMACEUTICA NV2 citations72
US8697683B2Apr 15, 2014

Azetidinyl diamides as monoacylglycerol lipase inhibitors

JANSSEN PHARMACEUTICA NV2 citations72
US12545677B2Feb 10, 2026

Compounds useful as factor XIa inhibitors

JANSSEN PHARMACEUTICA NV0 citations61
US8378117B2Feb 19, 2013

Hexahydro-cycloheptapyrazole cannabinoid modulators

JANSSEN PHARMACEUTICA NV2 citations61
US7183445B2Feb 27, 2007

Cyclohexyl derivatives as selective estrogen receptor modulators

JANSSEN PHARMACEUTICA NV2 citations61
US7732612B2Jun 8, 2010

7-amino alkylidenyl-heterocyclic quinolones and naphthyridones

JANSSEN PHARMACEUTICA NV3 citations60
US6825172B2Nov 30, 2004

3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents

JANSSEN PHARMACEUTICA NV2 citations58
US12286429B2Apr 29, 2025

5-oxo-1,2,3,5,8,8a-hexahydroindolizine-3-carboxamide derivatives useful as a factor XIa inhibitors

JANSSEN PHARMACEUTICA NV0 citations52
US9636345B2May 2, 2017

Benzimidazole derivatives useful TRPM8 channel modulators

JANSSEN PHARMACEUTICA NV0 citations52
US8981113B2Mar 17, 2015

Benzimidazole derivatives useful as TRPM8 channel modulators

JANSSEN PHARMACEUTICA NV0 citations52
US8759533B2Jun 24, 2014

Di-azetidinyl diamide as monoacylglcerol lipase inhibitors

JANSSEN PHARMACEUTICA NV1 citations52
US10118900B2Nov 6, 2018

Benzimidazole derivatives useful as CB-1 inverse agonists

JANSSEN PHARMACEUTICA NV1 citations51
US9067935B2Jun 30, 2015

Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators

JANSSEN PHARMACEUTICA NV0 citations51
US9434711B2Sep 6, 2016

Sulfonamides as TRPM8 modulators

JANSSEN PHARMACEUTICA NV0 citations49
US11814364B2Nov 14, 2023

Pyridine N-oxide derivatives useful as factor XIa inhibitors

JANSSEN PHARMACEUTICA NV0 citations48
US8987247B2Mar 24, 2015

Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders

JANSSEN PHARMACEUTICA NV0 citations46
US7776855B2Aug 17, 2010

Antimicrobial oxazolidinone prodrugs

JANSSEN PHARMACEUTICA NV1 citations44
US10590083B2Mar 17, 2020

Pyridin-2-one derivatives of formula (I) useful as EP3 receptor antagonists

JANSSEN PHARMACEUTICA NV0 citations42
US10399944B2Sep 3, 2019

Pyridin-2-one derivatives of formula (III) useful as EP3 receptor antagonists

JANSSEN PHARMACEUTICA NV0 citations42
US10336701B2Jul 2, 2019

Pyridin-2-one derivatives of formula (II) useful as EP3 receptor antagonists

JANSSEN PHARMACEUTICA NV0 citations42
US9815790B2Nov 14, 2017

Chemically modified quinoline and quinolone derivatives useful as CB-1 inverse agonists

JANSSEN PHARMACEUTICA NV0 citations41
US9682940B2Jun 20, 2017

Indazole derivatives useful as CB-1 inverse agonists

JANSSEN PHARMACEUTICA NV0 citations41

ORTHO MCNEIL PHARM INC

6 patents

OHMEDA PHARMA PROD

4 patents

CONNOLLY PETER J

4 patents

BRANUM SHAWN T

2 patents

COATS STEVEN J

2 patents

MACIELAG MARK J

2 patents

ORTH MCNEIL PHARMACEUTICAL INC

1 patent

(unassigned)

1 patent

ZHANG YUE-MEI

1 patent

JETTER MICHELE C

1 patent

Showing the top 50 of 56 patents by PatentIndex Score.